SIGA Technologies
SIGA
#8719
Rank
NZ$0.38 B
Marketcap
NZ$5.37
Share price
-1.27%
Change (1 day)
-54.73%
Change (1 year)

SIGA Technologies (SIGA) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$0.11 Billion

According to SIGA Technologies's latest financial reports the company's total liabilities are NZ$0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

SIGA Technologies - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$35.64 M-29.54%
2024-12-31NZ$50.59 M-44.35%
2023-12-31NZ$90.91 M132.04%
2022-12-31NZ$39.18 M-33.78%
2021-12-31NZ$59.16 M113.04%
2020-12-31NZ$27.77 M-81.44%
2019-12-31NZ$0.14 B-0.15%
2018-12-31NZ$0.14 B-77.25%
2017-12-31NZ$0.65 B1.76%
2016-12-31NZ$0.64 B-5.77%
2015-12-31NZ$0.68 B32.17%
2014-12-31NZ$0.51 B141.51%
2013-12-31NZ$0.21 B128.16%
2012-12-31NZ$94.32 M48.39%
2011-12-31NZ$63.56 M227.74%
2010-12-31NZ$19.39 M-24.92%
2009-12-31NZ$25.83 M106.98%
2008-12-31NZ$12.48 M78.34%
2007-12-31NZ$6.99 M-26.92%
2006-12-31NZ$9.57 M127.72%
2005-12-31NZ$4.2 M93.4%
2004-12-31NZ$2.17 M157.79%
2003-12-31NZ$0.84 M-32.81%
2002-12-31NZ$1.25 M-21.76%
2001-12-31NZ$1.6 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
NZ$2.88 B 2,370.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.05 B 1,652.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$95 M-18.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$1.83 M-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$1.75 B 1,403.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.37 B 1,076.54%๐Ÿ‡บ๐Ÿ‡ธ USA